Consistently, Invokana medication falls under the scrutiny of the FDA due to the severe adverse event associated with the drug. Recently a study conducted by David Polidori and colleagues found that the diabetic drug Invokana Increases Appetite in the patient who loses their weight due to the medication. As per the study the people got hungrier and ate more than they were eating before taking Invokana. The study was published in Obesity during Obesity Week 2016. There are thousands of lawsuits has been filed against Janssen Pharmaceuticals alleging that the manufacturers Fails to warn patients of the risks associated with Invokana. The growing numbers of patients who took Invokana medication and develop serious health problems are considering legal action.
Invokana, (canagliflozin) is one of several “new generation” type 2 diabetes drugs known as SGLT2 inhibitors was released by U.S Food and Drugs Administration in the U.S. market in 2013. The FDA warned about potentially fatal side effects of Invokana. Although Invokana was approved by the United States Food and Drug Administration the drug is associated with several life-threatening adverse effects including kidney problems, ketoacidosis, coma, heart attack, Foot and Leg Amputation and bone fractures. It is manufactured by Janssen Pharmaceuticals, a division of Johnson & Johnson. Janssen also markets Invokamet, a combination of canagliflozin and metformin. FDA advised that before prescribing Invokana or Farxiga, physicians and healthcare providers should screen patients to avoid adverse events cause by the drug.
The company is facing thousands of Invokana lawsuits due to serious injury caused by the drug. Due to the increasing number of Invokana lawsuits over the company Judicial Panel for Multidistrict Litigation has issued an order stating that all the lawsuits from districts in Georgia, Illinois, Kentucky, Missouri, Louisiana, Minnesota, Virginia and West Virginia are consolidated to the New Jersey District Court before U.S. District Judge Brian R. Martinotti. In all the lawsuits the allegations are similar. The plaintiff’s claims that manufacturers failed to provide adequate warnings and communications to the medical community and end line consumers of the increased risk of serious and life threatening medical complications associated with these drug.
The FDA has to take action to protect consumers from dangerous medicines and ban these life threatening drugs from the market. Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of Invokana medication. It will help FDA for further investigations as well as in clinical trials. If you or someone you love who was prescribed Invokana and then suffered from ketoacidosis, kidney failure, Heart Attack or Stroke may be eligible to file a personal injury lawsuit against the drug’s manufacturer. The Drugsclaim Lawyers and Attorneys are investigating claims that Invokana may be linked to kidney failure, cardiovascular complications and bone fractures. In filing personal injury lawsuits, injured patients seek compensation for medical expenses, lost work and pain and suffering, among other damages.
The post Invokana Medication Increases Appetite appeared first on Drugs Claim.